Institutional investors purchased a net $12.0 million shares of LLY during the quarter ended March 2016 and now own 65.11% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Pharmaceuticals: Major industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
VIKING GLOBAL INVESTORS LP Bought 11.8 Million shares of Eli Lilly and Co
THE VANGUARD GROUP, INC. Bought 2.0 Million shares of Eli Lilly and Co
RENAISSANCE TECHNOLOGIES LLC Bought 1.9 Million shares of Eli Lilly and Co